Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Structural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region.

Smith CD, Andersen AH, Gold BT; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2012;31 Suppl 3:S49-58.

2.

Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.

Hänggi J, Streffer J, Jäncke L, Hock C.

J Alzheimers Dis. 2011;26(4):719-34. doi: 10.3233/JAD-2011-101260.

PMID:
21709375
3.

Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.

Arlt S, Buchert R, Spies L, Eichenlaub M, Lehmbeck JT, Jahn H.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):335-44. doi: 10.1007/s00406-012-0350-7. Epub 2012 Sep 1.

PMID:
22940716
4.

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.

Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr.

Brain. 2007 Jul;130(Pt 7):1777-86. Epub 2007 May 28.

5.

Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.

Nho K, Risacher SL, Crane PK, DeCarli C, Glymour MM, Habeck C, Kim S, Lee GJ, Mormino E, Mukherjee S, Shen L, West JD, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative--ADNI.

Brain Imaging Behav. 2012 Dec;6(4):551-67. doi: 10.1007/s11682-012-9203-2.

6.

Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.

Yi HA, Möller C, Dieleman N, Bouwman FH, Barkhof F, Scheltens P, van der Flier WM, Vrenken H.

J Neurol Neurosurg Psychiatry. 2016 Apr;87(4):425-32. doi: 10.1136/jnnp-2014-309105. Epub 2015 Apr 22.

PMID:
25904810
7.

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Curr Alzheimer Res. 2009 Aug;6(4):347-61.

8.

Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.

Suppa P, Hampel H, Spies L, Fiebach JB, Dubois B, Buchert R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;46(1):199-209. doi: 10.3233/JAD-142280.

PMID:
25720402
9.

Brain structural alterations before mild cognitive impairment.

Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Jicha GA, Cooper G, Markesbery WR.

Neurology. 2007 Apr 17;68(16):1268-73.

PMID:
17438217
10.

Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.

Chetelat G, Baron JC.

Neuroimage. 2003 Feb;18(2):525-41.

PMID:
12595205
11.

Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study.

Ting WK, Fischer CE, Millikin CP, Ismail Z, Chow TW, Schweizer TA.

Curr Alzheimer Res. 2015;12(2):165-72.

PMID:
25654501
12.

Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.

Moon SW, Dinov ID, Kim J, Zamanyan A, Hobel S, Thompson PM, Toga AW.

J Alzheimers Dis. 2015;48(4):1051-63. doi: 10.3233/JAD-150335.

13.

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.

Kerbler GM, Fripp J, Rowe CC, Villemagne VL, Salvado O, Rose S, Coulson EJ; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2014 Nov 27;7:105-13. doi: 10.1016/j.nicl.2014.11.015. eCollection 2015.

14.

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.

Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2013 Feb 12;80(7):648-54. doi: 10.1212/WNL.0b013e318281ccd3. Epub 2013 Jan 9.

15.

A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up.

Scola E, Bozzali M, Agosta F, Magnani G, Franceschi M, Sormani MP, Cercignani M, Pagani E, Falautano M, Filippi M, Falini A.

J Neurol Neurosurg Psychiatry. 2010 Jul;81(7):798-805. doi: 10.1136/jnnp.2009.189639. Epub 2010 Apr 14.

PMID:
20392973
16.

Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.

Peng GP, Feng Z, He FP, Chen ZQ, Liu XY, Liu P, Luo BY.

CNS Neurosci Ther. 2015 Jan;21(1):15-22. doi: 10.1111/cns.12317. Epub 2014 Aug 21.

PMID:
25146658
17.

Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.

Da X, Toledo JB, Zee J, Wolk DA, Xie SX, Ou Y, Shacklett A, Parmpi P, Shaw L, Trojanowski JQ, Davatzikos C; Alzheimer's Neuroimaging Initiative.

Neuroimage Clin. 2013 Nov 28;4:164-73. doi: 10.1016/j.nicl.2013.11.010. eCollection 2014.

18.

Automated algorithm to measure changes in medial temporal lobe volume in Alzheimer disease.

Kazemifar S, Drozd JJ, Rajakumar N, Borrie MJ, Bartha R; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci Methods. 2014 Apr 30;227:35-46. doi: 10.1016/j.jneumeth.2014.01.033. Epub 2014 Feb 8.

PMID:
24518149
19.

Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.

Hsu JL, Lee WJ, Liao YC, Lirng JF, Wang SJ, Fuh JL.

PLoS One. 2015 Sep 15;10(9):e0137121. doi: 10.1371/journal.pone.0137121. eCollection 2015.

20.

Neuroanatomical correlates of awareness of illness in patients with amnestic mild cognitive impairment who will or will not convert to Alzheimer's disease.

Spalletta G, Piras F, Piras F, Sancesario G, Iorio M, Fratangeli C, Cacciari C, Caltagirone C, Orfei MD.

Cortex. 2014 Dec;61:183-95. doi: 10.1016/j.cortex.2014.10.010.

PMID:
25481475

Supplemental Content

Support Center